Novo Undercuts Lilly's Obesity Drug Price, Now Cheaper Than Car Payment  Just before the US cash session, Novo Nordisk A/S announced it will slash prices on Wegovy and Ozempic in a direct challenge to Eli Lilly's obesity drug, aiming to regain market share. The announcement comes just weeks after ......